Ocular Therapeutix Inc (OCUL)

Ocular Therapeutix Inc (OCUL) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.7B; returns 1 day -1.7%, 1 week -5.4%, 1 year -43.2%.

Ocular Therapeutix Inc. is an integrated biopharmaceutical company specializing in the development and commercialization of innovative therapies for ocular diseases, primarily leveraging its proprietary ELUTYX™ bioresorbable hydrogel-based formulation technology.

Groups OCUL belongs to

• Biopharmaceutical
• Ophthalmology
• Biotechnology
• Healthcare
• Clinical Stage Biopharma
• Long-Acting Injectables
• Commercial Stage Biotech
• Life Sciences
• Drug Discovery
• Pharmaceuticals

OCUL financial model: income statement, cash flow and balance sheet